Dacarbazine MEDAC

Dacarbazine Powder for solution for infusion

Therapeutic Indication:

Dacarbazine is indicated for the treatment of patients with metastasized malignant melanoma.
Further indications for Dacarbazine as part of a combination chemotherapy are:

  • Advanced Hodgkin’s disease as a second line.
  • Advanced adult soft tissue sarcomas (except mesothelioma, Kaposi sarcoma).


  • Composition: Oxaliplatin 5 mg/ml.
  • Pharmaceutical Form: Powder for Solution for Infusion.
  • Method of Administration: Intravenous.
  • How Supplied: Single vials of 200 mg, 500 mg and 1000 mg.
  • Manufacturer: Medac GmbH, Germany.

Contact Us

Contact us today to find out more about our services and discuss your enquiries.